Ola Winqvist

SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn.

ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden.

Goodwill Industries of North Louisiana, Inc. provides vocational programs and employment services for people with disabilities and in disadvantaged conditions. It offers multiple job resource centers, equipped with job-search experts, computers, Internet access and telephones. The firm also offers programs and contract services. The company was founded in 1926 and is headquartered in Shreveport, LA.

TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden.